| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Revenue | $191.2M | -22.8% |
| Cost of Revenue | $103.1M | -22.6% |
| Gross Profit | $88.1M | -22.9% |
| R&D Expense | $6.4M | +15.6% |
| SG&A Expense | $42.6M | +3.3% |
| Operating Income | -$12.7M | +77.5% |
| Pre-tax Income | -$12.3M | +77.9% |
| Income Tax | -$249K | -102.7% |
| Net Income | -$12.0M |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.9M | +12.4% |
| Accounts Receivable | $26.8M | -7.0% |
| Inventory | $99.7M | -18.0% |
| Current Assets | $157.6M | -12.3% |
| Total Assets | $243.6M | -12.3% |
| Current Liabilities | $23.0M | -14.8% |
| Total Liabilities | $51.7M | -30.9% |
| Line Item | 2023-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $30.7M | +271.0% |
| Capital Expenditures | $1.3M | -61.7% |
| Investing Cash Flow | -$4.8M | +85.6% |
| Financing Cash Flow | -$23.5M | -328.5% |
| Free Cash Flow | $29.4M | +237.7% |
| +81.5% |
| EPS (Basic) | -$0.90 | +80.7% |
| EPS (Diluted) | -$0.90 | +80.7% |
| Stockholders' Equity |
| $191.9M |
| -5.5% |